Chemodex

5-Bromo-2'-deoxyuridine

CHF 61.00
In stock
CDX-B0301-G0011 gCHF 61.00
CDX-B0301-G0055 gCHF 231.00
More Information
Product Details
Synonyms 5-BrdU; 5-Bromo-1-(2-deoxy-β-D-ribofuranosyl)uracil; 5-Bromouracil deoxyriboside; BUdR; Bromodeoxyuridine; Broxuridine; NSC 38297
Product Type Chemical
Properties
Formula

C9H11BrN2O5

MW 307.1
CAS 59-14-3
RTECS YU7350000
Purity Chemicals ≥99% (HPLC)
Appearance White powder.
Solubility Soluble in DMSO (30mg/ml), DMF (30mg/ml) or ethanol (25mg/ml) or water (10mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key WOVKYSAHUYNSMH-RRKCRQDMSA-N
Smiles O[C@H]1C[C@H](N2C=C(Br)C(NC2=O)=O)O[C@@H]1CO
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

The synthetic nucleoside 5-Bromo-2'-deoxyuridine (BrdU) is a thymidine analog used to label DNA and commonly used in the detection of proliferating cells in living tissues. It can be incorporated into newly synthesized DNA in place of thymidine during the S phase of the cell cycle. Cells that were actively proliferating can then be detected by denaturing the DNA and allowing specific antibodies with fluorescent tags to target the BrdU incorporation for detection via flow cytometry or fluorescence microscopy. Binding of the antibody requires denaturation of the DNA, usually by exposing the cells to acid or heat. BrdU is also used as a mutagen in genetic research. BrdU stimulates cellular differentiation and maturation in leukemia cell lines, while it inhibits differentiation of friend erythroleukemia cells. BrdU replaces Oct-4 in transcription factor-mediated reprogramming of somatic cells and can be used in small molecule cocktail to generate ciPSCs.

Product References

(1) N. Kee, et al.; J. Neurosci. Methods 115, 97 (2002) | (2) R.C. Leif, et al.; Cytometry A 58, 45 (2004) (Review) | (3) P. Taupin; Brain Res. Rev. 53, 198 (2007) (Review) | (4) D.W. Stacey & M. Hitomi; Cytometry A 73, 270 (2008) | (5) B.L. Cavanagh, et al.; Molecules 16, 7980 (2011) | (6) B. Lehner, et al.; Cell Tissue Res. 345, 313 (2011) | (7) T. Konishi, et al.; J. Radiat. Res. 52, 433 (2011) | (8) J.M. Barker, et al.; PLoS One 8, e63692 (2013) | (9) Y. Long, et al.; Cell Res. 25, 1171 (2015)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.